Iona Munjal
About
Iona Munjal is a scholar working on Epidemiology, Infectious Diseases and Surgery.
According to data from OpenAlex, Iona Munjal has authored 27 papers receiving a total of 125 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 10 papers in Infectious Diseases and 5 papers in Surgery. Recurrent topics in Iona Munjal's work include Respiratory viral infections research (11 papers), Pneumonia and Respiratory Infections (4 papers) and Bacterial Identification and Susceptibility Testing (4 papers). Iona Munjal is often cited by papers focused on Respiratory viral infections research (11 papers), Pneumonia and Respiratory Infections (4 papers) and Bacterial Identification and Susceptibility Testing (4 papers). Iona Munjal collaborates with scholars based in United States, United Kingdom and Japan. Iona Munjal's co-authors include Priya Nori, Belinda Ostrowsky, Susan K. Seo, Joshua D. Nosanchuk, Alejandra Gurtman, Yi Guo, Liise-anne Pirofski, Kena A. Swanson, Theresa Madaline and Philip Gialanella and has published in prestigious journals such as Clinical Infectious Diseases, Journal of Clinical Microbiology and The Journal of Infectious Diseases.
In The Last Decade
Iona Munjal
23 papers receiving 123 citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Iona Munjal United States | 7 | 81 | 35 | 31 | 19 | 18 | 27 | 125 | ||
| Gita Nadimpalli United States | 6 | 32 0.4× | 45 1.3× | 36 1.2× | 8 0.4× | 7 0.4× | 17 | 141 | ||
| Dagfinn Lunde Markussen Norway | 8 | 139 1.7× | 38 1.1× | 48 1.5× | 23 1.2× | 22 1.2× | 17 | 206 | ||
| Samantha Potgieter South Africa | 3 | 73 0.9× | 92 2.6× | 69 2.2× | 18 0.9× | 5 0.3× | 7 | 185 | ||
| Saray Mormeneo Bayo Spain | 6 | 60 0.7× | 29 0.8× | 21 0.7× | 19 1.0× | 6 0.3× | 26 | 118 | ||
| Suppachok Kirdlarp Thailand | 7 | 30 0.4× | 78 2.2× | 26 0.8× | 12 0.6× | 5 0.3× | 19 | 156 | ||
| Alleyna Claxton United Kingdom | 5 | 54 0.7× | 50 1.4× | 53 1.7× | 10 0.5× | 9 0.5× | 9 | 128 | ||
| Manuela M. Bergman United States | 2 | 63 0.8× | 47 1.3× | 51 1.6× | 13 0.7× | 17 0.9× | 2 | 142 | ||
| Lorenzo Maria Canziani Italy | 5 | 59 0.7× | 44 1.3× | 11 0.4× | 9 0.5× | 12 0.7× | 16 | 106 | ||
| Tomer Ziv Israel | 5 | 23 0.3× | 42 1.2× | 25 0.8× | 22 1.2× | 9 0.5× | 7 | 146 | ||
| Javier Cobo Reinoso Spain | 6 | 56 0.7× | 62 1.8× | 21 0.7× | 11 0.6× | 9 0.5× | 16 | 117 |
Countries citing papers authored by Iona Munjal
Since
Specialization
Citations
This map shows the geographic impact of Iona Munjal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iona Munjal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iona Munjal more than expected).
Fields of papers citing papers by Iona Munjal
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Iona Munjal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iona Munjal. The network helps show where Iona Munjal may publish in the future.
Co-authorship network of co-authors of Iona Munjal
This figure shows the co-authorship network connecting the top 25 collaborators of Iona Munjal. A scholar is included among the top collaborators of Iona Munjal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iona Munjal. Iona Munjal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Madhi, Shabir A., Beate Kampmann, Eric A. F. Simões, et al.. (2025). Preterm Birth Frequency and Associated Outcomes From the MATISSE (Maternal Immunization Study for Safety and Efficacy) Maternal Trial of the Bivalent Respiratory Syncytial Virus Prefusion F Protein Vaccine. Obstetrics and Gynecology. 145(2). 147–156.
2.
Walsh, Edward E., Daniel Eiras, John Woodside, et al.. (2025). Efficacy, Immunogenicity, and Safety of the Bivalent Respiratory Syncytial Virus (RSV) Prefusion F Vaccine in Older Adults Over 2 RSV Seasons. Clinical Infectious Diseases. 81(6). e680–e689.
3.
Davis, Mark M., William Towner, Elliot DeHaan, et al.. (2025). P-596. Immunobridging Demonstrating Effectiveness of the Bivalent Respiratory Syncytial Virus (RSV) Prefusion F Subunit Vaccine in Adults 18-59 Years of Age at High Risk of Severe RSV Disease in a Phase 3 Trial: The C3671023 MONeT Study Results. Open Forum Infectious Diseases. 12(Supplement_1).
4.
Neutel, Joel M., Kevin Cannon, Ryan Newton, et al.. (2025). Safety and Immunogenicity of Concomitant Administration and Combined Administration of Bivalent BNT162b2 COVID-19 Vaccine and Bivalent RSVpreF Respiratory Syncytial Virus Vaccine with or Without Quadrivalent Influenza Vaccine in Adults ≥ 65 Years of Age. Vaccines. 13(2). 158–158.
5.
Ilangovan, Kumar, David Radley, Michael A. Patton, et al.. (2025). Integrated Analysis of the Safety Experience in Adults with the Bivalent Respiratory Syncytial Virus Prefusion F Vaccine. Vaccines. 13(8). 827–827.
6.
Mikati, Tarek, Yasushi Fukushima, Daniel Eiras, et al.. (2025). P-605. Bivalent RSV Prefusion F-Based Subunit Vaccine Generates High and Durable Neutralizing Titers Across an Entire RSV Season among Older Adults. Open Forum Infectious Diseases. 12(Supplement_1).
7.
Eiras, Daniel, Yasushi Fukushima, Qin Jiang, et al.. (2024). RSVpreF Vaccine Elicits a Robust and Durable Immune Response Among Adults Aged 60 Years and Older Across an Entire RSV Season. A2998–A2998.
8.
Baker, Jeffrey T., Negar Aliabadi, Iona Munjal, et al.. (2024). Equivalent immunogenicity across three RSVpreF vaccine lots in healthy adults 18–49 years of age: Results of a randomized phase 3 study. Vaccine. 42(13). 3172–3179.
9.
Otsuki, Takeo, Kenzo Kosaka, Iona Munjal, et al.. (2024). Efficacy and safety of bivalent RSVpreF maternal vaccination to prevent RSV illness in Japanese infants: Subset analysis from the pivotal randomized phase 3 MATISSE trial. Vaccine. 42(22). 126041–126041.
10.
Law, Amy, et al.. (2023). Episodic Cost of Lower Respiratory Tract Illness due to Respiratory Syncytial Virus Among US Infants During the First Year of Life. The Journal of Infectious Diseases. 230(2). 480–484.
11.
Munjal, Iona, Jill Dreyfus, Holly Yu, et al.. (2022). Staphylococcus aureus infections after elective pediatric surgeries. Infection Control and Hospital Epidemiology. 43(11). 1625–1633.
12.
Choi, Jaeun, et al.. (2018). Predictors of inadequate initial echocardiography in suspected Kawasaki disease: Criteria for sedation. Congenital Heart Disease. 13(3). 470–475.
13.
Munjal, Iona. (2018). Infection Control and Isolation Considerations for the Pediatric Practitioner. Pediatrics in Review. 39(3). 107–120.
14.
Soma, Vijaya L, et al.. (2018). Epidemiology of and Risk Factors for Harmful Anti-Infective Medication Errors in a Pediatric Hospital. The Joint Commission Journal on Quality and Patient Safety. 44(10). 599–604.
15.
Nori, Priya, Theresa Madaline, Iona Munjal, et al.. (2017). Developing Interactive Antimicrobial Stewardship and Infection Prevention Curricula for Diverse Learners: A Tailored Approach. Open Forum Infectious Diseases. 4(3). ofx117–ofx117.
16.
Gialanella, Philip, et al.. (2017). Fulminant Sepsis Due to Granulibacter bethesdensis in a 4-Year-Old Boy With X-Linked Chronic Granulomatous Disease. The Pediatric Infectious Disease Journal. 36(12). 1165–1166.
17.
Szymczak, Wendy, Philip Gialanella, Iona Munjal, et al.. (2016). Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry as a First-Line Diagnostic Modality in Bacterial Meningitis and Septicemia: a Report of Five Cases. Clinical Microbiology Newsletter. 38(7). 57–60.
18.
Lee, Philip, et al.. (2016). Evaluation of a Pharmacy Directed Vancomycin and Monitoring Pilot Program at an Academic Pediatric Hospital. Open Forum Infectious Diseases. 3(suppl_1).
19.
Rodriguez‐Barradas, Maria C., José A. Serpa, Iona Munjal, et al.. (2014). Quantitative and Qualitative Antibody Responses to Immunization With the Pneumococcal Polysaccharide Vaccine in HIV-Infected Patients After Initiation of Antiretroviral Treatment: Results From a Randomized Clinical Trial. The Journal of Infectious Diseases. 211(11). 1703–1711.
20.
Munjal, Iona, et al.. (2010). Isolation Precautions. Pediatrics in Review. 31(12). 525–527.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Gita Nadimpalli Breakdown of academic impact, for papers by Dagfinn Lunde Markussen Breakdown of academic impact, for papers by Samantha Potgieter Breakdown of academic impact, for papers by Saray Mormeneo Bayo Breakdown of academic impact, for papers by Suppachok Kirdlarp Breakdown of academic impact, for papers by Alleyna Claxton Breakdown of academic impact, for papers by Manuela M. Bergman Breakdown of academic impact, for papers by Lorenzo Maria Canziani Breakdown of academic impact, for papers by Tomer Ziv Breakdown of academic impact, for papers by Javier Cobo Reinoso